Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BRIDGEBIO PHARMA | 17 | - | +1,71 % | ||
| INCYTE | 16 | 25 | -2,04 % | ||
| KINIKSA PHARMACEUTICALS | 14 | 11 | +23,48 % | ||
| WAVE LIFE SCIENCES | 9 | 2 | -3,88 % | ||
| AMGEN | 7 | 27 | -0,41 % | ||
| BEONE MEDICINES LTD ADR | 7 | 10 | -0,79 % | ||
| ERASCA | 7 | 2 | 0,00 % | ||
| ZAI LAB LTD ADR | 6 | 6 | 0,00 % | ||
| ROCKET PHARMACEUTICALS | 5 | - | -1,36 % | ||
| BIONTECH | 4 | 13 | -0,17 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04:53 | Ihre wichtigsten Termine: Alphabet, Meta, Microsoft, Amazon, Ebay, Biogen & Mercedes-Benz legen Zahlen vor | 137 | wallstreetONLINE | © Foto: Dall-EGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 06:45 Uhr, Schweiz:... ► Artikel lesen | |
| 04:26 | Relay Therapeutics (RLAY) Falls Hard on Profit-Taking From 74% April Jump | 1 | Insider Monkey | ||
| 04:26 | Patient Death Drags Erasca (ERAS) Shares by 48% | 1 | Insider Monkey | ||
| 03:26 | Mesoblast Achieves Key Patient Recruitment Milestone for Chronic Low Back Pain Trial | 1 | Finance News Network | ||
| 03:06 | Mesoblast completes enrollment in back pain therapy trial | 1 | Investing.com | ||
| 03:00 | Mesoblast Limited: Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain | 1 | GlobeNewswire (USA) | ||
| 02:35 | Mesoblast shares in focus after key Phase 3 milestone for low back pain | 1 | The Motley Fool Australia | ||
| 02:27 | Why Kiniksa Pharmaceuticals International Stock Raced Nearly 24% Higher Today | 1 | The Motley Fool | ||
| 01:54 | Oruka Therapeutics prices $700M stock offering at $72.50/share | 3 | Investing.com | ||
| 01:48 | Oruka Therapeutics, Inc.: Oruka Therapeutics Announces Pricing of Upsized $700 Million Underwritten Public Offering | 1 | GlobeNewswire (USA) | ||
| 00:50 | MESOBLAST LIMITED: Patient Recruitment Target Achieved in CLBP Pivotal Trial | - | ASX | ||
| 00:06 | Stifel raises Mirum Pharmaceuticals price target on pipeline outlook | 1 | Investing.com | ||
| Di | Oppenheimer raises Incyte stock price target on earnings beat | 3 | Investing.com | ||
| Di | Pfizer's victory in delaying Vyndamax generics is mixed bag for BridgeBio: analysts | 7 | FiercePharma | ||
| Di | Incyte Welcomes Suky Upadhyay as EVP, CFO | 3 | Contract Pharma | ||
| Di | BofA raises BridgeBio Pharma stock price target on Pfizer settlement clarity | 9 | Investing.com | ||
| Di | Pacira BioSciences Files Definitive Proxy Materials and Mails Letter to Shareholders | 1 | GlobeNewswire (USA) | ||
| Di | Morgan Stanley raises Incyte stock price target on solid results | 4 | Investing.com | ||
| Di | Trevi Therapeutics, Inc.: Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026 | 1 | GlobeNewswire (USA) | ||
| Di | Incyte: Morgan Stanley hebt Kursziel nach soliden Ergebnissen an | 3 | Investing.com Deutsch |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.